Exacerbation indicators in patients with noninvasive home ventilation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00029273

Enrollment

Registered

2022-06-13

Start date

2022-06-30

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J44.0 J96.11

Interventions

Group 1: - Study inclusion: disease status, quality of life, therapy, NIV settings, Intensified readout of NIV device data. - Quarterly follow-up: Disease status, quality of life, therapy, NIV settin

Eligibility

Sex/Gender

All

Age

18 Years to 120 Years

Inclusion criteria

Inclusion criteria: - Patients with pre-existing COPD of any stage according to GOLD with established NIV therapy. - Consent to privacy policy and patient education - Cognitive and verbal ability to answer the questionnaires

Exclusion criteria

Exclusion criteria: - Patient age <18 years - Deafness, Alexia - Not able to give consent

Design outcomes

Primary

Measure	Time frame
Primary descriptive: comparison of NIV device data and telemonitoring data from patients with COPD exacerbation on existing NIV therapy.	—

Secondary

Measure	Time frame
1. symptom documentation before and after exacerbation event. 2. identification of breathing patterns in device data and corresponding symptom patterns.	—

Countries

Germany

Contacts

Public ContactMaximilian Wollsching-Strobel

Kliniken der Stadt Köln gGmbH, Lungenklinik Standort-Merheim, Universität Witten/Herdecke

wollschingstrobelm@kliniken-koeln.de+ 49 221 8907 - 18929

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026